Fida Biosystems
Mike Hyatt is an experienced sales professional in the life sciences and analytical instrumentation sectors, currently serving as the Director of Sales West at Fida Biosystems since April 2024. Prior to this role, Mike held various sales positions at SomaLogic as Associate Director of Life Sciences Sales, and at Unchained Labs, where responsibilities included Manager of Western Analytical Sales and multiple sales roles. Additional experience includes positions at Tecan, Thermo Fisher Scientific, BioTek Instruments, and Alpha Innotech. Mike began a career in sales after earning a Bachelor of Science degree in Cell & Molecular Biology from San Diego State University.
This person is not in any offices
Fida Biosystems
Fida Biosystems offers a new proprietary technology developed for quantification and characterization of proteins and nanoparticles from 0.5 to 1,000 nm Dh, incl. antibodies, liposomes, exosomes, membrane embedded proteins et al. Based on accurate, in-solution, absolute measurements of hydrodynamic radius, the technology provides precise information about Kd, concentration, size, stoichiometry, conformational changes, oligomeric state, immunogenicity, multiple bindings etc. It is characterised by being fast (minutes), requiring very small sample amounts (ul-nl), and being exceptionally tolerant to the sample matrix, incl. plasma, serum, cell lysate, fermentation media etc. Contrary to most other procedures, the methodology is based on binding in homogenous solution; complications related to non-specific surface adsorption and challenging assay development are therefore avoided. I.e. the unique features of the FIDA technology enable characterisation and quantification in native (biorelevant) environments and in-built assay quality control and automation.